14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 8 May 2024

Trading levels for SNGX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.434 5.29 %
R2 0.426 3.48 %
R1 0.421 2.35 %
Current price: 0.412
Support S1 0.407 -1.28 %
S2 0.402 -2.41 %
S3 0.394 -4.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.472 14.62 %
R2 0.470 14.13 %
R1 0.435 5.71 %
Current price 0.412
Support S1 0.406 -1.46%
S2 0.389 -5.61%
S3 0.383 -6.99%

SNGX Predictions History

3 years ago
David Gold predicted that SNGX for 2021-02-12 is going

Rank:

3 years ago
JS predicted that SNGX for 2021-02-12 is going $2.13 (-0.47%)

3 years ago
JS predicted that SNGX for 2021-01-19 is going $1.47 (2.80%)

3 years ago
Longv587 predicted that SNGX for 2021-01-19 is going $1.55 (8.39%)

Rank:

3 years ago
JS predicted that SNGX for 2020-11-20 is going $2.35 (6.82%)

3 years ago
JS predicted that SNGX for 2020-11-19 is going $2.16 (-10.74%)

3 years ago
David.Pierce.8003 predicted that SNGX for 2020-11-19 is going

Rank:

3 years ago
JS predicted that SNGX for 2020-07-01 is going $2.03 (1.00%)

3 years ago
olaposi gafaru predicted that SNGX for 2020-07-01 is going

Rank:

3 years ago
JS predicted that SNGX for 2020-06-22 is going $1.79 (1.13%)

Click to get the best stock tips daily for free!

About Soligenix, Inc

Soligenix Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an ... SNGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT